Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.

Farizo KM, Burns DL, Finn TM, Gruber MF, Pratt RD.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S28-31. doi: 10.1093/infdis/jit532. Review.

PMID:
24626869
2.

Possible options for new pertussis vaccines.

Meade BD, Plotkin SA, Locht C.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S24-7. doi: 10.1093/infdis/jit531. Review.

PMID:
24626868
3.

Changing pertussis epidemiology: everything old is new again.

Clark TA.

J Infect Dis. 2014 Apr 1;209(7):978-81. doi: 10.1093/infdis/jiu001. Review.

PMID:
24626532
4.

Licensed pertussis vaccines in the United States. History and current state.

Klein NP.

Hum Vaccin Immunother. 2014;10(9):2684-90. doi: 10.4161/hv.29576. Epub 2014 Nov 6. Review.

5.

Development of improved vaccines against whooping cough: current status.

Marzouqi I, Richmond P, Fry S, Wetherall J, Mukkur T.

Hum Vaccin. 2010 Jul;6(7):543-53. Epub 2010 Jul 1. Review.

PMID:
20448470
6.

Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.

Burns DL, Meade BD, Messionnier NE.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S32-5. doi: 10.1093/infdis/jit491. Review. No abstract available.

PMID:
24626870
7.

Pertussis: pertussis control strategies and the options for improving current vaccines.

Plotkin SA.

Expert Rev Vaccines. 2014 Sep;13(9):1071-2. doi: 10.1586/14760584.2014.944166. Epub 2014 Aug 4.

PMID:
25090359
8.

Do we need a new vaccine to control the re-emergence of pertussis?

Mills KH, Ross PJ, Allen AC, Wilk MM.

Trends Microbiol. 2014 Feb;22(2):49-52. doi: 10.1016/j.tim.2013.11.007.

PMID:
24485284
9.

Pertussis control: time for something new?

Clark TA, Messonnier NE, Hadler SC.

Trends Microbiol. 2012 May;20(5):211-3. doi: 10.1016/j.tim.2012.03.003. Epub 2012 Apr 9.

PMID:
22494804
10.

Re-emergence of pertussis: what are the solutions?

Libster R, Edwards KM.

Expert Rev Vaccines. 2012 Nov;11(11):1331-46. doi: 10.1586/erv.12.118. Review. Erratum in: Expert Rev Vaccines. 2013 Feb;12(2):240-2.

PMID:
23249233
11.

Nonhuman primate and human challenge models of pertussis.

Merkel TJ, Halperin SA.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S20-3. doi: 10.1093/infdis/jit493. Review.

12.

Acellular pertussis vaccines: what lies ahead?

Wiedermann BL.

Contemp Pediatr. 1995 Sep;12(9):25-8, 30, 32 passim. Review.

PMID:
10155576
13.

Resurgence of pertussis calls for re-evaluation of pertussis animal models.

van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, van Els CA.

Expert Rev Vaccines. 2012 Sep;11(9):1121-37. doi: 10.1586/erv.12.83. Review.

PMID:
23151168
14.

[Pertussis vaccine. Reemergence of the disease and new vaccination strategies].

Moraga-Llop FA, Campins-Martí M.

Enferm Infecc Microbiol Clin. 2015 Mar;33(3):190-6. doi: 10.1016/j.eimc.2015.02.001. Epub 2015 Feb 20. Spanish.

PMID:
25707329
15.
16.

Public health. The pertussis paradox.

Allen A.

Science. 2013 Aug 2;341(6145):454-5. doi: 10.1126/science.341.6145.454. No abstract available.

PMID:
23908204
17.

Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology.

Pesco P, Bergero P, Fabricius G, Hozbor D.

Epidemics. 2014 Jun;7:13-21. doi: 10.1016/j.epidem.2014.04.001. Epub 2014 Apr 13.

19.

The United States research strategy on pertussis.

La Montagne JR.

Dev Biol Stand. 1997;89:25-8. Review.

PMID:
9272332

Supplemental Content

Support Center